• The incidence of screened disorders were 1:1 873 for congenital hypothyroidism, 1:14 544 for phenylketonuria, 1:3 526 for amino acid, organic acid and fatty acid disorders, 1:9 030 for classical congenital adrenal hyperplasia, 1:8 300 for biotinidase deficiency, 1:2 384 for sickle-cell disease and 1:121 for sickle-cell traits. (who.int)
  • Background and Objectives We investigated outcomes in a UK neonatal cohort as a benchmark for care of children with sickle cell disease (SCD). (haematologica.org)
  • Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. (nih.gov)
  • The incidence of neonatal GBS-related diseases can be decreased through the administration of antibiotic prophylaxis during childbirth in pregnant women who are carriers. (beds.ac.uk)
  • 1978) states, "screening is a process by which individuals are identified who may have disease or disorders that are otherwise undetected" and which many have "findings of asymptomatic cases" (Haggard & Hughes, 1991). (wikipedia.org)
  • Neonatal hearing screening (NHS) has been routinely offered as a vital component of early childhood care in developed countries, whereas such a screening program is still at the pilot or preliminary stage as regards its nationwide implementation in developing countries. (biomedcentral.com)
  • Universal screening might be considered as the prioritized implementation goal especially in those relatively developed provinces of China as it provides the best health and economic effects, while targeted screening might be temporarily more realistic than universal screening in those relatively developing provinces of China. (biomedcentral.com)
  • NHS has been routinely offered as a vital component of early childhood care in developed countries, whereas such a screening program is still at the pilot or preliminary stage as regards its nationwide implementation in developing countries where hearing care services, such as the provision of hearing aids, only cover approximately 1% of all the population [ 13 ]. (biomedcentral.com)
  • The implementation of the universal GBS screening program decreased the infection rate of neonatal early-onset GBS diseases. (beds.ac.uk)
  • The implementation of all comprehensive screening policies can help understand the status of pregnant women with GBS infection. (beds.ac.uk)
  • Neonatal screening achieved 87% coverage of births, with a false-alarm rate of 1.5%, and an overall yield of 90 cases of bilateral PCHI of 40 dB or more relative to hearing threshold level per 100,000 target population, equivalent to 80% of the expected prevalence of the disorder in the population. (nih.gov)
  • Coverage of neonatal screening in the population reached 95% in 2010. (who.int)
  • Newborn hearing screening programmes exist in many countries, including the United States, the United Kingdom and New Zealand. (wikipedia.org)
  • Screening personnel vary also, in some regions Audiologists are used, whereas technicians, nurses, or volunteers are used in other programmes. (wikipedia.org)
  • In addition to meeting these targets, one of the key challenges for newborn hearing screening programmes is to reduce 'loss to follow-up' (where a child doesn't return for the next stage of the process). (wikipedia.org)
  • The Joint Committee on Infant Hearing (US) has reported that this is a significant problem in state screening programmes in the United States and other jurisdictions. (wikipedia.org)
  • This study aimed to evaluate the role of GGT as a screening marker among diverse etiologies of infantile cholestasis. (biomedsearch.com)
  • In a screened population, the rate of referral for services before 6 months is 19 times higher than in an unscreened population. (medscape.com)
  • Between 1993 and 1996, two teams of four part-time testers and equipment moved between two pairs of hospitals to achieve four periods with neonatal screening and four without neonatal screening, each of 4-6 months' duration. (nih.gov)
  • As a result of this project, a historical article will be written for a peer-reviewed journal accessible to clinicians, researchers, and policy experts who are considering how best to expand universal metabolic screening. (clinicaltrials.gov)